S.Biomedics Statistics
Total Valuation
S.Biomedics has a market cap or net worth of KRW 327.33 billion. The enterprise value is 333.40 billion.
Market Cap | 327.33B |
Enterprise Value | 333.40B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
Earnings Date | Nov 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
S.Biomedics has 11.86 million shares outstanding. The number of shares has increased by 3.70% in one year.
Current Share Class | 11.86M |
Shares Outstanding | 11.86M |
Shares Change (YoY) | +3.70% |
Shares Change (QoQ) | +0.82% |
Owned by Insiders (%) | 22.60% |
Owned by Institutions (%) | 0.01% |
Float | 8.60M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 19.15 |
PB Ratio | 21.95 |
P/TBV Ratio | 45.65 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -37.72 |
EV / Sales | 19.50 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -47.81 |
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 1.28.
Current Ratio | 2.17 |
Quick Ratio | 1.91 |
Debt / Equity | 1.28 |
Debt / EBITDA | n/a |
Debt / FCF | -2.74 |
Interest Coverage | -7.77 |
Financial Efficiency
Return on equity (ROE) is -65.37% and return on invested capital (ROIC) is -14.52%.
Return on Equity (ROE) | -65.37% |
Return on Assets (ROA) | -10.83% |
Return on Invested Capital (ROIC) | -14.52% |
Return on Capital Employed (ROCE) | -20.31% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.48 |
Inventory Turnover | 3.66 |
Taxes
In the past 12 months, S.Biomedics has paid 104.25 million in taxes.
Income Tax | 104.25M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.52% in the last 52 weeks. The beta is 1.83, so S.Biomedics's price volatility has been higher than the market average.
Beta (5Y) | 1.83 |
52-Week Price Change | -20.52% |
50-Day Moving Average | 21,366.00 |
200-Day Moving Average | 21,522.00 |
Relative Strength Index (RSI) | 73.38 |
Average Volume (20 Days) | 102,810 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, S.Biomedics had revenue of KRW 17.10 billion and -8.84 billion in losses. Loss per share was -754.38.
Revenue | 17.10B |
Gross Profit | 7.77B |
Operating Income | -6.18B |
Pretax Income | -7.40B |
Net Income | -8.84B |
EBITDA | -4.32B |
EBIT | -6.18B |
Loss Per Share | -754.38 |
Balance Sheet
The company has 20.42 billion in cash and 19.13 billion in debt, giving a net cash position of 1.28 billion or 108.34 per share.
Cash & Cash Equivalents | 20.42B |
Total Debt | 19.13B |
Net Cash | 1.28B |
Net Cash Per Share | 108.34 |
Equity (Book Value) | 14.91B |
Book Value Per Share | 637.43 |
Working Capital | 13.77B |
Cash Flow
In the last 12 months, operating cash flow was -3.99 billion and capital expenditures -2.98 billion, giving a free cash flow of -6.97 billion.
Operating Cash Flow | -3.99B |
Capital Expenditures | -2.98B |
Free Cash Flow | -6.97B |
FCF Per Share | -588.03 |
Margins
Gross margin is 45.44%, with operating and profit margins of -36.12% and -51.70%.
Gross Margin | 45.44% |
Operating Margin | -36.12% |
Pretax Margin | -43.29% |
Profit Margin | -51.70% |
EBITDA Margin | -25.29% |
EBIT Margin | -36.12% |
FCF Margin | n/a |
Dividends & Yields
S.Biomedics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.70% |
Shareholder Yield | n/a |
Earnings Yield | -2.70% |
FCF Yield | -2.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
S.Biomedics has an Altman Z-Score of 4.3 and a Piotroski F-Score of 3.
Altman Z-Score | 4.3 |
Piotroski F-Score | 3 |